GVR Report cover Australia Facial Injectables Market Size, Share & Trends Report

Australia Facial Injectables Market Size, Share & Trends Analysis Report By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), By Application, And Segment Forecasts, 2021 - 2028

  • Published Date: Sep, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-4-68038-325-6
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 65

Report Overview

The Australia facial injectables market size was valued at USD 1.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 26.3% from 2021 to 2028. Increasing awareness about aesthetic procedures among consumers and the growing geriatric population are factors anticipated to drive the market. Furthermore, the shift in trend from invasive to minimally invasive procedures and advancements in facial rejuvenation are additional factors expected to support market growth over the forecast period.

Australia facial injectables market size, by product, 2018 - 2028 (USD Million)

Advancements in procedure techniques coupled with the introduction of novel products, procedures are anticipated to aid dermatologists or physicians treat multiple facial areas and customize treatments for individual patients as well as enable the use of a combination of products to obtain better outcomes. These factors are expected to contribute to the growth of the market for facial injectables in Australia over the forecast period.

The Covid-19 pandemic resulted in an increase in virtual consultations. For instance, the British Association of Aesthetic Plastic Surgeons (BAAPS) reported an increase of 70% in requests for virtual consultations in the UK. Similarly, the U.S. reported a 64% hike in virtual consultation requests, as patients were considering undergoing treatments after the pandemic.

According to Wiley One Library, manufacturing firms in Taiwan, South Korea, the U.S., and Israel had to decrease the production of components used in laser-based devices in the first and second quarters of 2020, which impacted the supply chain. This led to a decrease in production in 2020.

The cosmeceuticals (self-care) market witnessed a low impact amid the pandemic due to an increase in online purchases, while invasive and minimally invasive markets, such as aesthetic surgeries, reported high impact due to closure of aesthetic facilities and postponement of appointments. The noninvasive market, which includes injectable fillers and laser-based aesthetic treatments, witnessed the moderate-to-high impact and is expected to rebound at a moderate-to-high recovery rate.

Product Insights

The Hyaluronic Acid (HA) segment dominated the market and accounted for the largest revenue share of 54.9% in 2020. This is attributed to increasing demand as a dermal filler or in cosmetic preparations due to strong water retention properties and deep penetration in the epidermis. The Botulinum toxin type A segment is expected to be the fastest-growing segment during the forecast period owing to the rising application of BoNTA in cosmetics (esthetics), for improving the facial appearance, and reducing the signs of aging 

Cosmetic-grade HA has a low molecular weight that facilitates deep penetration of the product in the epidermis, helping in retaining water in the cells and releasing antioxidants that delay the aging process. HA is used in healing wounds, skin ulcers, and burns as well as acts as a moisturizer. It is also used as a lip filler in plastic surgery. The HA segment is expected to dominate the market over the forecast period, owing to an increase in the use of HA as dermal filler or in cosmetic injectables.

Application Insights

The aesthetics segment dominated the Australia facial injectables market and accounted for more than 70.0% in 2020 due to rising spending on aesthetic procedures and growing awareness for aesthetic procedures among consumers. The therapeutic segment is expected to register a double-digit CAGR over the forecast period. This is attributed to increasing applications of facial injectables in the treatment of blepharospasm, strabismus or crossed eyes, Meige's syndrome, Oromandibular Dystonia (OMD), Hemifacial Spasms (HFS), and focal hyperhidrosis.

Australia facial injectables market share, by application, 2020 (%)

The aesthetics segment is expected to witness a CAGR of 26.5%in the market for facial injectables in Australia over the forecast period, due to growing awareness about aesthetic procedures and rising disposable income. An increase in the use of facial injectable for parentheses lines, wrinkles on the face, lip lines, lip augmentation, lip border restoration, perioral lines, and crow’s feet lines is expected to aid market growth.

Key Companies & Market Share Insights

The market participants are involved in multiple strategic alliances to establish themselves in the market. For instance, in June 2021, SILK Laser Australia Limited entered into an agreement to acquire Beauty Services Holdings Pty Ltd, which operates Australian Skin Clinics in Australia, and The Cosmetic Clinic in New Zealand. This acquisition is anticipated to strengthen SILK’s market position. Some of the prominent players in the Australia facial injectables market include:

  • SILK Laser Clinics

  • Advanced Clinics Australia

  • Results Laser Clinic

  • Australian Skin Clinics

  • Laser Clinics Australia

Australia Facial Injectables Market Report Scope

Report Attribute

Details

Market size value in 2021

USD 2.9 billion

Revenue forecast in 2028

USD 15.0 billion

Growth Rate

CAGR of 26.3% from 2021 to 2028

Base year for estimation

2020

Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application

Key companies profiled

SILK Laser Clinics; Advanced Clinics Australia; Results Laser Clinic; Australian Skin Clinics; Laser Clinics Australia

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the Australia facial injectables market report on the basis of product and application: 

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Collagen

    • Hyaluronic Acid (HA)

    • Botulinum Toxin Type A

    • Calcium Hydroxylapatite (CaHA) 

    • Polymer Fillers

      • Polymethylmethacrylate Microspheres (PMMA)

      • PLLA (Poly-L-lactic acid)

  • Application Outlook (Revenue, USD Million, 2016 - 2028)

    • Aesthetics

    • Therapeutics

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.